157 related articles for article (PubMed ID: 7449379)
1. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
Roy S; Brenner PF; Marrs RP; Mishell DR
Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
[TBL] [Abstract][Full Text] [Related]
2. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
Scher J; Jeng DY; Kerenyi TD
Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
[TBL] [Abstract][Full Text] [Related]
3. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories.
Marrs RP; Brenner PF; Roy S; Mishell DR
Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157
[TBL] [Abstract][Full Text] [Related]
4. Termination of very early pregnancy by vaginal suppositories-(15S)-15-methyl prostaglandin F2 alpha methyl ester.
Wan LS; Stiber AJ; Turkel J
Contraception; 1981 Dec; 24(6):603-15. PubMed ID: 6173156
[TBL] [Abstract][Full Text] [Related]
5. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
Brenner PF; Marrs RP; Roy S; Mishell DR
Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
[TBL] [Abstract][Full Text] [Related]
6. Vaginal administration of 15-methyl-PGF2 alpha methyl ester for preoperative cervical dilatation. Task force on prostaglandins for fertility regulation. The World Health Organization.
Contraception; 1981 Mar; 23(3):251-9. PubMed ID: 7016432
[TBL] [Abstract][Full Text] [Related]
7. Menses induction and second-trimester pregnancy termination using a polymeric controlled release vaginal delivery system containing (15S)15-methyl PGF2 alpha methyl ester.
Bygdeman M; Christenssen N; Gréen K; Vesterqvist O; Roseman TJ; Tuttle ME; Spilman CH
Contraception; 1983 Feb; 27(2):141-51. PubMed ID: 6303690
[TBL] [Abstract][Full Text] [Related]
8. Postconceptional induction of menses with double prostaglandin F2 alpha impact.
Borten M; Friedman EA
Am J Obstet Gynecol; 1984 Dec; 150(8):1006-7. PubMed ID: 6507528
[TBL] [Abstract][Full Text] [Related]
9. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
Mandelin M
Prostaglandins; 1978 Jul; 16(1):143-52. PubMed ID: 704921
[TBL] [Abstract][Full Text] [Related]
10. Termination of second trimester pregnancy with a long-acting vaginal pessary containing 15-methyl-PGF2 alpha methyl ester.
Int J Gynaecol Obstet; 1983 Apr; 21(2):159-65. PubMed ID: 6136437
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandins and abortion. III. Comparison of single intra-amniotic injections of 15-methyl prostaglandin F2alpha and prostaglandin F2alpha for termination of second-trimester pregnancy: an international multicenter study. World Health Organization Tast Force on the Use of Prostaglandins forthe Regulation of Fertility.
Am J Obstet Gynecol; 1977 Nov; 129(6):601-6. PubMed ID: 920761
[TBL] [Abstract][Full Text] [Related]
12. Methods to determine success of attempts to terminate early gestation pregnancies with prostaglandin vaginal suppositories.
Brenner PF; Marrs RP; Roy S; Mishell DR
Contraception; 1983 Aug; 28(2):111-24. PubMed ID: 6196152
[TBL] [Abstract][Full Text] [Related]
13. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
Bolognese RJ; Corson SL
Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
[TBL] [Abstract][Full Text] [Related]
14. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
[TBL] [Abstract][Full Text] [Related]
15. The effect of a 15(S)-15-methyl prostaglandin F2 alpha (methyl ester) suppository upon termination of early pregnancy.
Roux JF; Southern E; Gutknecht G
Contraception; 1980 Jul; 22(1):57-61. PubMed ID: 7418407
[TBL] [Abstract][Full Text] [Related]
16. Early first-trimester abortion induction by Silastic vaginal devices for continuous release of 15(S)=15-methyl prostaglandin F2alpha methyl ester.
Robins J
Fertil Steril; 1977 Oct; 28(10):1048-55. PubMed ID: 561712
[TBL] [Abstract][Full Text] [Related]
17. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
Lauersen NH; Wilson KH
Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
[TBL] [Abstract][Full Text] [Related]
18. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
Nilsson S; Zador G; Nygren KG; Wide L
Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
[TBL] [Abstract][Full Text] [Related]
19. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
Bygdeman M; Gréen K; Lundström V; Ramadan M; Fotiou S; Bergström S
Prostaglandins; 1976; 12 Suppl():27-51. PubMed ID: 968064
[TBL] [Abstract][Full Text] [Related]
20. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
Wagatsuma T; Tabuchi T; Tabei T; Kaku R
Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]